Skip to main content

Table 1 Clinical features of LGSC cases

From: Expression of hypothalamic-pituitary-gonadal axis-related hormone receptors in low-grade serous ovarian cancer (LGSC)

Case no

Age

FIGO stage

Residual disease

Chemotherapy

Chemosensitivity

Follow-up (months)

Survival Outcomes

1

57

IIIC

R0

Y

Y

21

Censored

2

39

IIIC

≥1 cm

Y

Y

20

Alive

3

77

IC

R0

NA

NA

NA

Censored

4

27

IIIC

≥1 cm

Y

N

18

Died

5

46

IIIC

≥1 cm

Y

N

32

Alive

6

68

IIIC

0.1-1 cm

Y

NA

12

Died

7

49

IIIC

0.1-1 cm

Y

N

52

Alive

8

42

IIIC

≥1 cm

Y

N

13

Censored

9

76

IIIB

R0

Y

Y

22

Alive

10

57

IIIC

0.1-1 cm

Y

Y

20

Alive

11

54

IIIC

0.1-1 cm

Y

N

19

Alive

12

75

IIIC

R0

Y

N

70

Alive

13

61

IB

R0

Y

NA

19

Censored

14

39

IB

R0

Y

Y

56

Alive

15

54

IIIB

0.1-1 cm

Y

Y

53

Alive

16

34

IC

R0

Y

Y

30

Alive

17

60

IIIC

R0

Y

Y

41

Alive

18

40

IA

R0

Y

Y

20

Alive

19

40

IA

R0

Y

Y

59

Alive

20

53

IIIC

0.1-1 cm

Y

N

30

Died

21

57

IIIC

R0

Y

Y

22

Alive

22

43

IIIC

0.1-1 cm

Y

Y

45

Alive

23

35

IIIC

R0

Y

Y

87

Alive

24

55

IIIC

R0

Y

Y

50

Alive

25

69

IV

0.1-1 cm

Y

Y

27

Died

26

62

IIIC

0.1-1 cm

Y

N

52

Died